Stage IV HR-Positive Invasive Ductal Carcinoma: Dee's Patient Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- ER-positive
- Sex
- Female
- Spread to
- Bones
- Treatment
- chemotherapy, surgery, radiation and targeted therapy
- Outcome
- Living With Cancer
Treatment course, step by step
- Neoadjuvant AC-T chemotherapy
- bilateral mastectomy
- radiotherapy
- ribociclib after bone metastases were found in 2023.
What happened, in summary
Dee was 31 and breastfeeding in 2017 when pain in her left breast was followed by a large lump. Her symptoms were initially minimized because of her age, but she kept pushing for answers and eventually had an ultrasound through a private hospital. She was diagnosed with Stage III breast cancer involving invasive ductal carcinoma and ductal carcinoma in situ, and the cancer was ER-positive. Treatment began with neoadjuvant AC-T chemotherapy, followed by a bilateral mastectomy and radiotherapy. The treatment was physically and emotionally difficult. Dee dealt with radiation burns, a painful capsular contracture around her implant, identity loss, and later PTSD. Trying to return to normal too quickly also contributed to health setbacks, including pneumonia and hospitalization. In 2023, Dee learned that the cancer had spread to her bones, changing her diagnosis to Stage IV metastatic breast cancer. She adjusted to new treatment with ribociclib and focused on rebuilding life around her mental health, her children, and support from an online cancer community. As of October 2024, Dee was living with metastatic breast cancer while continuing to embrace time with her family and the life she had rebuilt. Her story also emphasizes self-advocacy after early symptoms were dismissed and the importance of emotional care after physical treatment.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer